- Founded
- 2022
- Employees
- 115
About Synapticure
Personalized virtual clinical care is finally here for neurodegenerative diseases like Alzheimer's and related Dementias (Cognitive), Parkinson's and Huntington's (Movement), and ALS (Motor neuron). We provide a novel approach to care in these diseases, centering a patient and caregiver around a coordinator who quarterbacks patients through our full Multi-Disciplinary Care Resources to local aid, PT/OT and home health support. When you leave our clinic, it's not with a handful of paper referrals, but with our coordinators helping you book and find the best physicians, DME, trials, and even cheapest prescriptions. We are devoted to helping patients, from guidance on care and insurance to providing the full spectrum of investigational and clinical testing to improve outcomes. Synapticure was built by leading patient and caregiver advocates alongside leading clinicians, biotech executives and telemedicine executives to bring the neurodegenerative disease care and treatment experience into the 21st century, and is backed by the leading Venture funds and investors in the remote health and life sciences space.
Leadership at Synapticure
The team at the top of the org chart.
Sandra Abrevaya
Co-Founder & CEO
47 reports
Eric Anderson
VP, Clinical Operations & Care Delivery
23 reports
Graham Spencer
CTO
4 reports
Suzie Sheetz
Svp, Head Of Growth
3 reports
Aaron Gitler
VP of Science
3 reports
Christie Byrne
Head of Product
2 reports
Kathleen Beach
Vp, People
1 report
Peter Wallach
Co-Founder, CFO
1 report
Martina De Majo
Scientific Advisor
Board
Juan Reyes
Advisor
Maya Carter
Advisor
Maceo Carter
Advisor
Terri Long
Advisor
Hope Maruzo
Advisor
Jim Contreras
Advisor